Chemoinformaics analysis of 3,4-Dimethoxy cinnamaldehyde
| Molecular Weight | 192.214 | nRot | 4 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 8 |
| Exact Molecular Weight | 192.079 | nRing | 1 |
| Solubility: LogS | -2.47 | nHRing | 0 |
| Solubility: LogP | 1.477 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 28.7775 |
| nHD | 0 | BPOL | 16.3785 |
| QED | 0.54 |
| Synth | 1.977 |
| Natural Product Likeliness | 0.706 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.477 |
| HIA | 0.012 |
| CACO-2 | -4.568 |
| MDCK | 0.000013 |
| BBB | 0.987 |
| PPB | 0.795176 |
| VDSS | 0.999 |
| FU | 0.164499 |
| CYP1A2-inh | 0.965 |
| CYP1A2-sub | 0.909 |
| CYP2c19-inh | 0.236 |
| CYP2c19-sub | 0.754 |
| CYP2c9-inh | 0.029 |
| CYP2c9-sub | 0.902 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.909 |
| CYP3a4-inh | 0.035 |
| CYP3a4-sub | 0.244 |
| CL | 8.279 |
| T12 | 0.8 |
| hERG | 0.089 |
| Ames | 0.421 |
| ROA | 0.044 |
| SkinSen | 0.926 |
| Carcinogencity | 0.893 |
| EI | 0.963 |
| Respiratory | 0.925 |
| NR-Aromatase | 0.09 |
| Antiviral | No |
| Prediction | 0.702726 |